Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
PAK6 encodes a member of a family of p21-stimulated serine/threonine protein kinases, which contain an amino-terminal Cdc42/Rac interactive binding (CRIB) domain and a carboxyl-terminal kinase domain. De plus, nous expédions P21-Activated Kinase 6 Protéines (10) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 164 products:
Human Polyclonal PAK6 Primary Antibody pour IHC, ELISA - ABIN1002959
Jaffer, Chernoff: p21-activated kinases: three more join the Pak. dans The international journal of biochemistry & cell biology 2002
Show all 3 Pubmed References
Dog (Canine) Polyclonal PAK6 Primary Antibody pour IHC (p) - ABIN4343483
Kwek, Dao, Roy, Hou, Alajajian, Simko, Small, Fong: Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients. dans Journal of immunology (Baltimore, Md. : 1950) 2012
Human Polyclonal PAK6 Primary Antibody pour ELISA, ICC - ABIN4343485
Raja, Sahasrabuddhe, Radhakrishnan, Syed, Solanki, Puttamallesh, Balaji, Nanjappa, Datta, Babu, Renuse, Patil, Izumchenko, Prasad, Chang, Rangarajan, Sidransky, Pandey, Gowda, Chatterjee: Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells. dans Oncotarget 2016
Study shows that high PAK6 expression is associated with poor prognosis and increased chemoresistance to 5-FU/oxaliplatin chemotherapy of gastric tumor.
RhoD recruits Pak6 to the plasma membrane to antagonize RhoC (Montrer RHOC Anticorps) signaling during cell contraction and blebbing
PAK6 localization to cell-cell adhesions is Cdc42 (Montrer CDC42 Anticorps)-dependent
p21-activated kinase 6 (PAK6) as a novel interactor of leucine-rich repeat kinase 2 (LRRK2 (Montrer LRRK2 Anticorps)), a kinase involved in Parkinson's disease
PAK6 is directly targeted by miR (Montrer MLXIP Anticorps)-328. miR (Montrer MLXIP Anticorps)-328 inhibits cell growth and promotes cell apoptosis in prostate cancer cells.
negative correlation between PAK6 and EZH2 (Montrer EZH2 Anticorps) expression was observed in hepatoma tissues from HCC (Montrer FAM126A Anticorps) patients. These data identified the tumor suppressive role and potential underlying mechanism of PAK6 in hepatocarcinogenesis
the results of the present study suggested that miR (Montrer MLXIP Anticorps)-429 inhibits the migration and invasion of colon cancer cells, partly at least, by mediating the expression of PAK6, as well as the activity of cofilin (Montrer CFL1 Anticorps) signaling
we report that in colon cancer PAK6 promotes tumor progression and chemoresistance both in vitro and in vivo
PAK6 is specifically required for carcinoma cell-cell dissociation downstream of hepatocyte growth factor (HGF (Montrer HGF Anticorps)) for both DU145 prostate cancer and HT29 colon cancer cells.
PAK5 plays an essential role in the initiation and progression of hepatocellular carcinoma.
data suggest that PAK-6 p21 (Montrer D4S234E Anticorps)-activated kinase plays a role in weight gain unrelated to exercise and caloric intake
functional deficits in PAK5 (Montrer PAK7 Anticorps), PAK6 and PAK5/PAK6 knockout mice
Our results indicate that Pak5 (Montrer PAK7 Anticorps) and Pak6 together are not required for viability, but are required for a normal level of locomotion and activity as well as for learning and memory.
This gene encodes a member of a family of p21-stimulated serine/threonine protein kinases, which contain an amino-terminal Cdc42/Rac interactive binding (CRIB) domain and a carboxyl-terminal kinase domain. These kinases function in a number of cellular processes, including cytoskeleton rearrangement, apoptosis, and the mitogen-activated protein (MAP) kinase signaling pathway. The protein encoded by this gene interacts with androgen receptor (AR) and translocates to the nucleus, where it is involved in transcriptional regulation. Changes in expression of this gene have been linked to prostate cancer. Alternative splicing results in multiple transcript variants.
p21(CDKN1A)-activated kinase 6
, serine/threonine-protein kinase PAK 6
, p21-activated kinase 6
, p21 (CDKN1A)-activated kinase 6
, p21 protein (Cdc42/Rac)-activated kinase 6